Open Orphan plc will be rebranding to hVIVO plc on 26 October 2022, learn more here.

Assay Development

Ensuring optimised readouts for assays.

Custom Assay Development

hLAB’s capabilities for custom assay Development, Validation and tech Transfer to FDA, EMA and ICH guidelines according to GCLP ensuring optimised readouts for assays. Custom assay development extends to a wide range of assay types including viral infectivity assays, anti-viral drugs efficacy assessments, quantitative and qualitative diagnostic real-time RT-PCR, virus microneutralization assays and cell mediated immunity assessments including ELISA assays for the anti-drug antibody analysis, cytokines and chemokines biomarker, ELISpot and Flow Cytometry analysis.

If you’re a potential customer, job seeker, health professional or an investor, find out how hVIVO can help you.

Contact hVIVO
chevron-down